News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

EXACT Sciences Corporation (EXAS) Reports First-Quarter 2014 Financial Results



5/1/2014 3:01:39 PM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Exact Sciences Corp. (Nasdaq: EXAS) today announced its financial results for the quarter March 31, 2014.

Exact reported total revenues of $0.3 million for the first quarter of 2014, compared to $1.0 million for the first quarter of 2013. Our revenue has been comprised of the non-cash amortization of up-front license fee payments paid to us by Genzyme Corp., which was amortized over a five-year collaboration period ending in January 2014.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES